
No results matched your search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
OBSV | NASDAQ | USD | Real-time | |
OBSN | Switzerland | CHF | Delayed | |
22D | Frankfurt | EUR | Delayed |
Geneva, Switzerland and Boston, MA – February 17, 2021 – ObsEva SA (NASDAQ:OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to...
Geneva, Switzerland and Boston, MA – Thursday 11 February, 2021 – ObsEva SA (NASDAQ:OBSV), a Swiss clinical-stage biopharmaceutical company focused on the development and...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Neutral | Sell | Sell | Buy | Sell |
Technical Indicators | Neutral | Strong Sell | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Sell | Sell | Strong Buy | Neutral |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Three Black Crows | 1D | Current | |||
Completed Patterns | |||||
Dragonfly Doji | 15 | 1 | Feb 24, 2021 21:30 | ||
Three Outside Down | 1H | 3 | Feb 24, 2021 18:00 | ||
Engulfing Bearish | 5H | 4 | Feb 22, 2021 21:00 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
NASDAQ | 4.28 | 4.30 | 4.57 | 4,265,738 | +1.42% | USD | 24/02 | ||
Switzerland | 4.00 | 4.00 | 4.05 | 74,807 | -4.08% | CHF | 12:18:32 | ||
Frankfurt | 9.2200 | 9.3400 | 9.6000 | 0 | 0.00% | EUR | 04/02 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Dangote Cement | 208.50 | 208.50 | 208.50 | -11.50 | -5.23% | 18.30K | 11:55:00 | ||
UBA | 8.35 | 8.55 | 8.35 | -0.20 | -2.34% | 14.26M | 12:03:00 | ||
Zenith Bank | 25.95 | 26.20 | 25.90 | -0.35 | -1.33% | 11.31M | 12:01:00 | ||
Guaranty Trust Bank | 31.20 | 31.45 | 31.00 | +0.40 | +1.29% | 11.63M | 12:02:00 | ||
FBN Holdings | 7.35 | 7.45 | 7.30 | -0.10 | -1.35% | 3.76M | 12:00:00 | ||
Flour Mills of Nigeria | 28.35 | 28.35 | 28.35 | -0.50 | -1.73% | 152.76K | 12:00:00 | ||
Oando Plc | 3.50 | 3.70 | 3.35 | +0.09 | +2.64% | 11.40M | 12:01:00 | ||
Sterling Bank | 1.770 | 1.770 | 1.770 | 0.000 | 0.00% | 994.09K | 11:58:00 | ||
Wema Bank | 0.65 | 0.65 | 0.65 | 0.00 | 0.00% | 66.87K | 11:35:00 | ||
B O C Gases Nigeria PLC | 12.25 | 12.25 | 12.25 | -1.36 | -9.99% | 16.60K | 11:47:00 |
Obseva SA is a Switzerland-based company active in the pharmaceutical and medical research sector. The Company develops oral compounds to treat women’s reproductive health conditions from conception to birth. Its pipeline includes three product candidates: Linzagolix (OBE2109), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of endometriosis (phase 2b of clinical trials) and uterine fibroids (phase 3 of clinical trials); Nolasiban (OBE001), an oral oxytocin receptor antagonist undergoing phase 3 of clinical trials, with the potential to inhibit uterine contractions at the time of embryo transfer, thereby enhancing embryo implantation during assisted reproductive technologies (ART), and OBE022, an oral and selective prostaglandin F2 alpha (PGF2a) receptor antagonist designed to control preterm labor (phase 2a of clinical trials).
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review